New Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings have been scheduled this week to consider the safety of two Respiratory Syncytial Virus (RSV) vaccine candidates for seniors.
This U.S. Food and Drug Administration (FDA) vaccine committee includes industry leaders offering expert opinions in response to strategic questions.
Read More
